CDK4 and cancer: In cancer cells, RB is found to be frequently inactive, either because of direct genetic and epigenetic inactivation of the RB gene (also known as RB1) but more frequently by alterations that result in increased activity of the RB kinases Cyclin D-CDK4/6 and Cyclin E-CDK2 (reviewed in [3–6]).